Syndax Pharmaceuticals (SNDX) Net Margin (QoQ) (2015 - 2026)

Syndax Pharmaceuticals (SNDX) Net Margin (QoQ) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Syndax Pharmaceuticals 1.87 Bn 1.52 Bn 53.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1,928.00
Dec 31, 2025 4,709.00
Sep 30, 2025 6,776.00
Jun 30, 2025 22,243.00
Mar 31, 2025 80,372.00
Dec 31, 2024 -55,244.00
Sep 30, 2024 147,228.00
Dec 31, 2021 24,177.00
Sep 30, 2021 589,160.00
Jun 30, 2021 126,992.00
Mar 31, 2021 -199,849.00
Dec 31, 2020 2,963.00
Sep 30, 2020 -82,639.00
Jun 30, 2020 -44,274.00
Mar 31, 2020 -71,471.00
Dec 31, 2019 41,418.00
Sep 30, 2019 60,290.00
Jun 30, 2019 -45,620.00
Mar 31, 2019 68,622.00
Dec 31, 2018 8,080.00